Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines-Reference-Cited by-同舟云学术

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

Published:2022-07-22 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Hensler Michal¹,Rakova Jana¹,Kasikova Lenka¹,Lanickova Tereza¹²,Pasulka Josef¹,Holicek Peter¹²,Hraska Marek¹,Hrnciarova Tereza¹,Kadlecova Pavla¹,Schoenenberger Andreu¹,Sochorova Klara¹,Rozkova Daniela¹,Sojka Ludek¹²,Drozenova Jana³,Laco Jan⁴,Horvath Rudolf⁵,Podrazil Michal¹²,Hongyan Guo⁶,Brtnicky Tomas⁷,Halaska Michal J.⁸,Rob Lukas⁸,Ryska Ales⁴,Coosemans An⁹,Vergote Ignace⁹¹⁰¹¹,Garg Abhishek D.¹²,Cibula David¹³,Bartunkova Jirina¹²,Spisek Radek¹²,Fucikova Jitka¹²

Affiliation:

1. Sotio Biotech, Prague, Czech Republic

2. Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic

3. Department of Pathology 3rd Faculty of Medicine, And University Hospital Kralovske Vinohrady, Prague, Czech Republic

4. The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Czech Republic

5. Department of Pediatric and Adult Rheumatology, University Hospital Motol, Prague, Czech Republic

6. Department of Gynecology and Obstetrics, Peking University Third Hospital, Beijing, Hebei Province, China

7. Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic

8. Department of Gynecology and Obstetrics, Charles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic

9. Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Belgium

10. Department of Oncology, Leuven Cancer Institute, Laboratory of Gynaecologic Oncology, KU Leuven, Belgium

11. Department of Gynaecology and Obstetrics, Leuven Cancer Institute, UZ Leuven, Leuven, Belgium

12. Laboratory of Cell Stress and Immunity, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

13. Gynecologic Oncology Center, Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

Funder

Sotio Biotech

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2101596

Reference59 articles.

1. The hallmarks of successful anticancer immunotherapy

2. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

3. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma